Novartis raises 2019 guidance, helped by Sandoz generics unit

Novartis lifted full-year sales and profit targets on Thursday, helped by innovative medicine sales and as the Swiss drugmaker’s slimmed-down Sandoz generics unit saw accelerating revenue in markets outside the United States.

…read more

Source:: Reuters – Business News